TrialVaccine2023

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.

Gregory J Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.